Fortress Biotech, Inc.
FBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001429260
No open-market purchases or sales by Fortress Biotech, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $17.7M in total; no superinvestor holds it.
Other share classesFBIOP
Q4 2025 vs. Q3 2025
How the institutions holding Fortress Biotech, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 56 | 2 | 52 | −2 |
| Shares | 4.47M | 94.1K | 5.79M | +1.42M (+32.4%) |
| Value | $16.5M | $347.6K | $21.2M | +$5.10M (+31.7%) |
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Fortress Biotech, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Opaleye Management Inc. | 1,090,000 | $3.99M | 0.53% |
| Bridgeway Capital Management, LLC | 182,368 | $667.5K | 0.01% |
| Man Group plc | 52,653 | $192.7K | 0.00% |
| Quadrature Capital Ltd | 49,096 | $179.7K | 0.00% |
| Gsa Capital Partners LLP | 36,074 | $132.0K | 0.01% |
| Two Sigma Advisers, LP | 25,250 | $92.4K | 0.00% |
| XTX Topco Ltd | 14,433 | $52.8K | 0.00% |
| Carlson Financial, Inc. | 13,009 | $47.6K | 0.03% |
| Visionary Wealth Advisors | 11,235 | $41.1K | 0.00% |
| Forum Financial Management, LP | 10,000 | $36.6K | 0.00% |
| MTM Investment Management, LLC | 4,249 | $15.6K | 0.00% |
| Larson Financial Group LLC | 16 | $59 | 0.00% |
| Motiv8 Investments LLC | 33 | $0 | 0.00% |
Sold out (15)
Institutions that held Fortress Biotech, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Simplex Trading, LLC | 54,453 | $201.0K |
| HRT Financial LP | 46,130 | $170.0K |
| Acadian Asset Management LLC | 43,109 | $158.0K |
| Two Sigma Securities, LLC | 30,474 | $112.6K |
| Scientech Research LLC | 18,072 | $66.8K |
| Omers Administration Corp | 17,700 | $65.4K |
| Tme Financial, Inc. | 11,500 | $42.5K |
| Macquarie Group Ltd | 6,666 | $25.0K |
| Rockefeller Capital Management L.P. | 4,812 | $17.8K |
| Tower Research Capital LLC (TRC) | 4,783 | $17.7K |
| Citigroup Inc | 525 | $1.94K |
| Toth Financial Advisory Corp | 400 | $1.48K |
| SWAN Capital LLC | 250 | $924 |
| FMR LLC | 63 | $233 |
| SBI Securities Co., Ltd. | 1 | $4 |
Not filed for Q4 2025 yet (2)
Institutions that held Fortress Biotech, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Sheets Smith Investment Management | 73,142 | $270.3K |
| Cubist Systematic Strategies, LLC | 20,933 | $77.3K |